首批300例菠萝蛋白酶酶解清创治疗的单中心经验
本回顾性队列研究评估2015至2020年本院烧伤科使用Nexobrid®酶解清创(ED)治疗300例深度烧伤患者的临床结局。结果显示ED是快速去除焦痂和准确评估烧伤深度的可靠方法,常帮助避免不必要手术,尤其在上肢等功能精细部位;ED效果不受烧伤病因影响,不增加感染风险,但需警惕失血和早期发热。
要点
- ED是快速去除焦痂和准确评估烧伤深度的可靠方法,常帮助避免不必要手术。
- ED效果不受烧伤病因影响,不增加感染风险,但需警惕失血和早期发热。
- 瘢痕增生与手术相关,但本研究设计无法直接评估ED对瘢痕增生的影响。
核心结论
- ED是快速去除焦痂和准确评估烧伤深度的可靠方法,常帮助避免不必要手术,尤其在上肢等功能精细部位。
- ED效果不受烧伤病因影响,不增加感染风险,但需警惕失血和早期发热。
- 随时间推移,ED已成为本院烧伤治疗方案的核心工具;未来需研究其在大面积烧伤患者中的影响。
研究设计与样本
- 回顾性队列研究,纳入2015至2020年本院烧伤科收治的300例18岁以上深度真皮和全层烧伤患者。
- 排除化学/电烧伤、妊娠及对Nexobrid®过敏者;入院时评估烧伤深度,ED后重新评估。
- 主要终点为ED确定手术指征的可靠性(与传统临床评估比较);次要终点包括影响愈合时间的因素、并发症率和瘢痕增生。
主要发现
- 300例患者中男性76%,中位年龄41岁,火焰烧伤最常见(46.7%)。
- 中位烧伤总面积(TBSA)为8%,Nexobrid®治疗TBSA为5%;26例大面积烧伤患者接受序贯ED。
- 治疗后数据表明ED较初始评估改善了烧伤深度诊断,常使真皮烧伤降期;「阶梯征」成为真皮烧伤需植皮手术的有用预测指标。
- 烫伤与火焰烧伤在ED有效性方面无显著差异;ED与失血相关,高TBSA病例需谨慎;早期发热是需要警惕监测的因素。
- 瘢痕增生与手术相关,但本研究设计无法直接评估ED对肥厚的影响。
临床怎么用
- 作者认为ED是快速去除焦痂和准确评估烧伤深度的可靠方法,常帮助避免不必要手术,尤其在上肢等功能精细部位。
- 作者指出ED效果不受烧伤病因影响;ED不增加感染风险,但早期发热仍应仔细监测。
- 作者提到随时间推移ED已成为本院烧伤治疗方案的核心工具;未来需研究其在大面积烧伤患者中的影响。
局限性
- 本研究为回顾性队列研究。
- 本研究设计无法直接评估ED对瘢痕增生的影响。
- 未来需进一步研究探讨ED对大面积烧伤患者治疗的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This retrospective cohort study evaluates the clinical outcomes of enzymatic debridement (ED) with Nexobrid® in burn patients treated at our hospital's Burn Unit from 2015 to 2020. The primary aim was to determine whether Nexobrid® effectively reduces unnecessary surgeries and improves patient outcomes. METHODS: The study included 300 patients over 18 years old with deep dermal and full-thickness burns, excluding cases with chemical/electrical burns, pregnancy, and allergies to Nexobrid®. Burn depth was assessed upon admission and re-evaluated post-ED. The primary endpoint was the reliability of ED in determining surgical indications compared to traditional clinical assessments. Secondary endpoints included factors influencing healing time, complication rates, and scar hypertrophy. RESULTS: Among the 300 patients (76 % male, median age 41), flame burns were most common (46.7 %). Median total body surface area (TBSA) burned was 8 %, and TBSA treated with Nexobrid® was 5 %. Sequential ED was performed in 26 patients with larger burns. Post-treatment data indicated that ED improved burn depth diagnosis compared to initial assessments, often downstaging dermal burns. The "step sign" emerged as a useful predictor for graft surgery necessity in dermal burns. No significant differences were observed between scald and flame burns in ED effectiveness. ED was associated with blood loss, emphasizing caution in cases with high TBSA, and early fever was noted as a factor requiring vigilant monitoring. While scar hypertrophy was associated with surgery, this study design could not directly evaluate ED's impact on hypertrophy. CONCLUSION: We found ED to be a reliable method for rapid eschar removal and accurate burn depth evaluation, which often helped us avoid unnecessary surgeries-particularly important in delicate, functional areas like the upper limbs. Interestingly, the effectiveness of ED was not influenced by the burn's etiology when treating intermediate-depth injuries. While ED does not appear to rise the risk of infection, early fever should still be carefully monitored. Over time, ED has become a central tool in our burn treatment protocols. Future studies are needed to explore its impact on treating patients with extensive burns.
引用
- Bulla A, Rivas Nicolls DA, Lopez Martinez JA, et al. Single center experience of the first 300 patients treated with bromelain-based enzymatic debridement. Burns. 2025. PMID: 40279789. doi:10.1016/j.burns.2025.107508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。